|
|
negative regulation of ovulation
|
GO:0060280 |
1 |
0.994
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.972
|
|
|
|
adrenal cortex formation
|
GO:0035802 |
2 |
0.935
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.925
|
|
|
|
adrenal cortex development
|
GO:0035801 |
2 |
0.924
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.912
|
|
|
|
negative regulation of metanephric glomerulus development
|
GO:0072299 |
1 |
0.867
|
|
|
|
rhombomere 5 formation
|
GO:0021666 |
1 |
0.837
|
|
|
|
facial nerve structural organization
|
GO:0021612 |
10 |
0.763
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.757
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.729
|
|
|
|
posterior mesonephric tubule development
|
GO:0072166 |
2 |
0.728
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.720
|
|
|
|
rhombomere 3 morphogenesis
|
GO:0021658 |
2 |
0.665
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.658
|
|
|
|
negative regulation of metanephric glomerular mesangial cell proliferation
|
GO:0072302 |
1 |
0.639
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.636
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.635
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.615
|
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.609
|
|
|
|
s shaped body morphogenesis
|
GO:0072050 |
6 |
0.579
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.578
|
|
|
|
metanephric part of ureteric bud development
|
GO:0035502 |
2 |
0.546
|
|
|
|
thorax and anterior abdomen determination
|
GO:0007356 |
1 |
0.531
|
|
|
|
regulation of metanephric glomerular mesangial cell proliferation
|
GO:0072301 |
1 |
0.529
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.523
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.507
|
|
|
|
diaphragm development
|
GO:0060539 |
5 |
0.502
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.492
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.488
|
|
|
|
positive regulation of male gonad development
|
GO:2000020 |
6 |
0.486
|
|
|
|
rhombomere 3 development
|
GO:0021569 |
4 |
0.479
|
|
|
|
glomerulus vasculature development
|
GO:0072012 |
14 |
0.471
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.448
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.441
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.440
|
|
|
|
facial nerve development
|
GO:0021561 |
11 |
0.416
|
|
|
|
regulation of glomerular mesangial cell proliferation
|
GO:0072124 |
1 |
0.415
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.412
|
|
|
|
rhombomere 5 morphogenesis
|
GO:0021664 |
1 |
0.410
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.407
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.403
|
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
17 |
0.397
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.389
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.389
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.388
|
|
|
|
rhombomere 3 formation
|
GO:0021660 |
1 |
0.382
|
|
|
|
metanephric glomerulus vasculature development
|
GO:0072239 |
7 |
0.381
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.381
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.379
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900212 |
4 |
0.363
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.359
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.358
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.336
|
|
|
|
cranial nerve structural organization
|
GO:0021604 |
13 |
0.334
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.325
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.324
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.322
|
|
|
|
gamma delta t cell differentiation
|
GO:0042492 |
11 |
0.316
|
|
|
|
metanephric mesenchyme development
|
GO:0072075 |
10 |
0.313
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.307
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.301
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.300
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.295
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.293
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.292
|
|
|
|
dermatan sulfate proteoglycan metabolic process
|
GO:0050655 |
1 |
0.292
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.286
|
|
|
|
glomerular epithelial cell development
|
GO:0072310 |
6 |
0.283
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.281
|
|
|
|
facial nerve morphogenesis
|
GO:0021610 |
11 |
0.277
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.272
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.272
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
15 |
0.271
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.267
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.264
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.263
|
|
|
|
regulation of metanephric ureteric bud development
|
GO:2001074 |
1 |
0.258
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.251
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.239
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.237
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.235
|
|
|
|
renal system vasculature development
|
GO:0061437 |
15 |
0.231
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.225
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.225
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.225
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.224
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.220
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.217
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.217
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.211
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.211
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.210
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.208
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.204
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.202
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.201
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.199
|
|
|
|
regulation of gamma delta t cell activation
|
GO:0046643 |
9 |
0.196
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.195
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.193
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.193
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.193
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
14 |
0.192
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.192
|
|
|
|
negative regulation of metanephros development
|
GO:0072217 |
6 |
0.190
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.187
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.187
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.185
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.179
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.178
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.177
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.176
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.176
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.175
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.172
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.172
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.171
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.170
|
|
|
|
regulation of female gonad development
|
GO:2000194 |
7 |
0.169
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.169
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.167
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.166
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.166
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.164
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.162
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.161
|
|
|
|
protein export from nucleus
|
GO:0006611 |
20 |
0.157
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.156
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.156
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.155
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.154
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.153
|
|
|
|
seminiferous tubule development
|
GO:0072520 |
14 |
0.151
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.151
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.151
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.151
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.149
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.149
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.148
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.147
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.147
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.146
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.145
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.143
|
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
9 |
0.143
|
|
|
|
gamma delta t cell activation
|
GO:0046629 |
13 |
0.141
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.140
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.139
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.139
|
|
|
|
glomerular visceral epithelial cell development
|
GO:0072015 |
6 |
0.138
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.137
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.136
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.135
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.134
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.134
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.133
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.132
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.132
|
|
|
|
regulation of male gonad development
|
GO:2000018 |
7 |
0.132
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.131
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.130
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.129
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.129
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.128
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.126
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.126
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.126
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.126
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.125
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.125
|
|
|
|
mesenchymal to epithelial transition
|
GO:0060231 |
12 |
0.125
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.124
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.123
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.123
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.121
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.120
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.120
|
|
|
|
glomerular mesangium development
|
GO:0072109 |
5 |
0.120
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.120
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.119
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.118
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.117
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.117
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.117
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.116
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.116
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.115
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.114
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.114
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.114
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.114
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.113
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.113
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.113
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.112
|
|
|
|
metanephric comma shaped body morphogenesis
|
GO:0072278 |
1 |
0.111
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.109
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.108
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.108
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.108
|
|
|
|
cell proliferation involved in metanephros development
|
GO:0072203 |
9 |
0.106
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.106
|
|
|
|
comma shaped body morphogenesis
|
GO:0072049 |
5 |
0.105
|
|
|
|
male genitalia development
|
GO:0030539 |
20 |
0.105
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.105
|
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
19 |
0.105
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.105
|
|
|
|
lateral line nerve development
|
GO:0048892 |
1 |
0.104
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.103
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.102
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.102
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.100
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.100
|
|
|
|
adrenal gland development
|
GO:0030325 |
18 |
0.098
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.098
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.098
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.097
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.096
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.096
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.095
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.095
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.095
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.095
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.093
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.093
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.093
|
|
|
|
positive regulation of heart growth
|
GO:0060421 |
18 |
0.093
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.092
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.092
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.092
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.090
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.090
|
|
|
|
regulation of metanephric glomerulus development
|
GO:0072298 |
5 |
0.089
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.089
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.088
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.088
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.088
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.086
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.085
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.084
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.084
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.084
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.083
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.083
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.082
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.082
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.082
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.081
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.081
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.080
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.080
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.079
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.078
|
|
|
|
nuclear export
|
GO:0051168 |
34 |
0.078
|
|
|
|
regulation of t cell differentiation in thymus
|
GO:0033081 |
24 |
0.078
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.077
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.077
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.076
|
|
|
|
positive regulation of metanephric ureteric bud development
|
GO:2001076 |
1 |
0.076
|
|
|
|
sertoli cell development
|
GO:0060009 |
15 |
0.076
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.076
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.076
|
|
|
|
kidney mesenchyme development
|
GO:0072074 |
14 |
0.076
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.075
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.074
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.074
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.073
|
|
|
|
response to cocaine
|
GO:0042220 |
14 |
0.072
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.072
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.072
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.072
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.072
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.072
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
18 |
0.072
|
|
|
|
rhythmic behavior
|
GO:0007622 |
15 |
0.071
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.071
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.070
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.070
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.070
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.069
|
|
|
|
negative regulation of female gonad development
|
GO:2000195 |
3 |
0.069
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.068
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.068
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.068
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.068
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.068
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.067
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.067
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.066
|
|
|
|
neuromuscular synaptic transmission
|
GO:0007274 |
16 |
0.066
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.066
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.066
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.065
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
13 |
0.065
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.065
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.064
|
|
|
|
regulation of gamma delta t cell differentiation
|
GO:0045586 |
9 |
0.064
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.064
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.063
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.063
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.063
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.062
|
|
|
|
negative regulation of glomerular mesangial cell proliferation
|
GO:0072125 |
1 |
0.061
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.061
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.061
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.061
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.060
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.060
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.059
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.058
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.058
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.058
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.058
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.058
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.057
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.057
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.057
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.056
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.056
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.055
|
|
|
|
osteoblast development
|
GO:0002076 |
17 |
0.055
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.055
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.054
|
|
|
|
interleukin 1 mediated signaling pathway
|
GO:0070498 |
4 |
0.054
|
|
|
|
rhombomere development
|
GO:0021546 |
8 |
0.054
|
|
|
|
sertoli cell differentiation
|
GO:0060008 |
18 |
0.053
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.053
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.053
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.053
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.053
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.052
|
|
|
|
pericardium development
|
GO:0060039 |
16 |
0.052
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.052
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.051
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.051
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.051
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.051
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.051
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.051
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.050
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.050
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.050
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.050
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.050
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.050
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.050
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.049
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.049
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.049
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.049
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.048
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.048
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.048
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.048
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.048
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.047
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.047
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.047
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.046
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.046
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.046
|
|
|
|
ectoderm development
|
GO:0007398 |
15 |
0.046
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.046
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.046
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.045
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.045
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.044
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.044
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.044
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.044
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.044
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.044
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.043
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.043
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.043
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.043
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.042
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.042
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.042
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.042
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.042
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.042
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.042
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.041
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.041
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.041
|
|
|
|
regulation of mesenchymal cell apoptotic process
|
GO:2001053 |
14 |
0.041
|
|
|
|
negative regulation of mesenchymal cell apoptotic process
|
GO:2001054 |
11 |
0.041
|
|
|
|
response to gamma radiation
|
GO:0010332 |
22 |
0.040
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.039
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.039
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.039
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.039
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.039
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.039
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.038
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
20 |
0.038
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.038
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.038
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.038
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.038
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.038
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.038
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.038
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.038
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.038
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.037
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.037
|
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.037
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.037
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.036
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.036
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.036
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.036
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.036
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.035
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.035
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.035
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.035
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.035
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.035
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.035
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.034
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.034
|
|
|
|
muscle cell fate commitment
|
GO:0042693 |
11 |
0.034
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.034
|
|
|
|
regulation of protein sumoylation
|
GO:0033233 |
4 |
0.033
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.033
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.033
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.032
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.032
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.032
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.032
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.032
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.032
|
|
|
|
cellular response to heparin
|
GO:0071504 |
1 |
0.032
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.032
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.032
|
|
|
|
negative regulation of glomerulus development
|
GO:0090194 |
1 |
0.031
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.031
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.031
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.031
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.031
|
|
|
|
response to follicle stimulating hormone
|
GO:0032354 |
1 |
0.031
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.030
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.030
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.030
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.030
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.030
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.029
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.029
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.029
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.028
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.028
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.028
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.028
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.028
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.028
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.028
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.028
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.027
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.027
|
|
|
|
mesenchymal cell apoptotic process
|
GO:0097152 |
14 |
0.027
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.027
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.027
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.027
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.027
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.026
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.026
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.026
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.026
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.026
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.026
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.026
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.026
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.026
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.026
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.025
|
|
|
|
glomerular epithelial cell differentiation
|
GO:0072311 |
10 |
0.025
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.025
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.025
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.025
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.025
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.025
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.025
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.025
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.025
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.025
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
